The development of subsensitivity to chlorpheniramine.
The Journal of Allergy and Clinical Immunology
|July 1, 1985
Summary
Subsensitivity to antihistamines, like chlorpheniramine, develops within 7 to 21 days of treatment. This diminished drug effect, observed via skin prick tests (PSTs), cannot be fully reversed by increasing the dosage.
Area of Science:
- Pharmacology
- Immunology
- Dermatology
Background:
- Antihistamines are crucial for managing allergic reactions.
- Understanding the development of drug tolerance is essential for effective long-term treatment.
Purpose of the Study:
- To investigate the emergence of subsensitivity to antihistamines during therapy.
- To determine if increased dosage can overcome this diminished drug response.
Main Methods:
- A double-blind crossover study involving 10 subjects receiving chlorpheniramine or placebo.
- Titrated prick skin tests (PSTs) to histamine and antigen were performed at intervals.
- Wheal area, serum drug levels, and response to dosage increase were measured.
Main Results:
- Maximal skin test suppression occurred on days 3 or 7, with significantly less suppression by day 21.
- Doubling the chlorpheniramine dose did not restore maximal suppression.
- No significant correlation was found between serum drug levels and PST suppression.
Conclusions:
- Subsensitivity to antihistamines develops between 7 and 21 days of therapy.
- This tolerance cannot be fully overcome by doubling the dose.
- The mechanism may involve increased histamine H1 receptor numbers rather than induced metabolism.
Related Concept Videos
Desensitization and Tachyphylaxis
3.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.4K
Anticholinesterase Agents: Poisoning and Treatment
2.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K
Upper Respiratory Drugs: First and Second-Generation Antihistamines
1.8K
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
1.8K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
928
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
928
Drug Toxicity: Dose-Dependent Reactions
229
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
229
Drug Toxicity: Allergic Reactions
209
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
209


